HCP stock: buy or sell?
August 23rd, 2019
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States.
Should I buy HCP stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Following a trading plan helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Check the only buy setup that matches with HCP stock now:
|New all-time high||No|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is HCP stock a buy?
Financial institutions and banks post stock ratings everyday.At Stocks2.com, we detected 5 ratings published for HCP stock in the last 30 days. The general sentiment of these ratings is bullish for HCP stock, with 5 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-6-13||Raymond James||Market Perform||Outperform|
|2019-1-9||BMO Capital Markets||Market Perform||Outperform|
|2019-1-7||Robert W. Baird||Neutral||Outperform|
HCP stock analysis
Shares of HCP declined a disappointing -1.10% and closed at $34.15.
Shares of HCP declined a disappointing -1.10% and closed at $34.15. HCP shows a short term strength with several rising tops and rising bottoms. In the very short term, on Aug/21 it marked a new bottom at $33.72 that should act a support if HCP starts a trading flat base in the range of $33.72 - $34.75 Trading the long side, we should wait to a new breakout over $34.75 to find the next buy point. Since May when HCP stock price broke up the SMA100d line, it gained $4.92 (16.83%).
After climbing for 4 weeks, this week HCP slightly fell an unpleasant -0.96%, closing at $34.15.
HCP stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, HCP might consolidate in a flat-base, waiting to break out over or down under . Late April HCP price bounced up over the SMA of 20 weeks that acted as support stopping new slides.
HCP stock price history
HCP IPO was on May 23rd, 1985 at $0.01 per share1. Since then, HCP stock surged a 341,400.00%, with a yearly average of 10,041.20%. If you had invested right after HCP's IPO a $1,000 in HCP stock in 1985, it would worth $3,414,000.00 today.
1: Adjusted price after possible price splits or reverse-splits.
HCP stock historical price chart
HCP stock reached 52-week highs today at $34.92, and all-time highs 2013-05-22 with a price of 35.69.
HCP stock price target is $34.30Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' HCP stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 3 price targets for HCP stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-1||Stifel Nicolaus||Raises Target||$32.00||$34.00||6.3%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, HCP was in line with the forecasts of the experts and reported an EPS of $0.43 per share. Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw a slightly fine growth of 2.54% to $1,782.01 million USD. However, its income margin (compared to revenues) climbed to 59.54%, that is $1,061.09 million.
|2013||$2,110 M||-||$895 M42.4%||-|
|2014||$1,529 M||-27.55%||$922 M60.3%||3.07%|
|2015||$1,798 M||17.63%||$-559.24 M-31.1%||-160.64%|
|2016||$1,981 M||10.16%||$628 M31.7%||-212.25%|
|2017||$1,738 M||-12.27%||$414 M23.8%||-34.02%|
|2018||$1,782 M||2.54%||$1,061 M59.5%||156.20%|
Quarterly financial resultsHCP reported $426.62 million in revenues for 2018-Q4, a -3.31% less compared to previous quarter. Reported quarter income marked $831.55 M with a profit margin of 194.92%. Profit margin skyrocketed a 172.39% compared to previous quarter when profit margin was 22.52%. When comparing revenues to same quarter last year, HCP sales marked a neutral move and stayed steady a 0.55%. Looking back to recent quarterly results, HCP posted 3 positive quarters in a row.
|2017-Q2||$459 M||-||$19 M4.2%||-|
|2017-Q3||$429 M||-6.52%||$-8 M-1.8%||-139.71%|
|2017-Q4||$424 M||-1.10%||$-59 M-13.8%||666.64%|
|2018-Q1||$460 M||8.31%||$40 M8.8%||-168.54%|
|2018-Q2||$455 M||-1.08%||$90 M19.8%||123.56%|
|2018-Q3||$441 M||-2.95%||$99 M22.5%||10.48%|
|2018-Q4||$427 M||-3.31%||$832 M194.9%||736.81%|
|2019-Q1||$421 M||-1.34%||$61 M14.6%||-92.61%|
HCP ownershipWhen you are planning to invest in a company, it's worth to check its ownership structure.
HCP shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.22% of all shares.
Bearish positions for HCP stock account 0.00%, no big difference from last month.
For a better understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$16.3 B||$0.0 M||$227.9 M||$25.7 B||$34.1 B|
|Total shares||478.0 M||0.0 M||34.5 M||356.5 M||383.7 M|
|Float shares||489.8 M||177.2 M||22.4 M||371.3 M||404.4 M|
|- Institutional holdings (%)||97.0%||99.7%||42.8%||91.1%||86.6%|
|- Insider holdings (%)||0.2%||1.3%||32.4%||0.4%||0.2%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, August 23rd, 2019|
|Day range||$34.04 - $34.92|
|Average true range||$0.74|
|50d mov avg||$32.58|
|100d mov avg||$31.44|
|200d mov avg||$30.17|
HCP performanceTo better understand HCP performance you must becnhmark its gains with other related stocks in same sector or industry. In the following table, we compare HCP performance to Sabra Health Care, Tiptree, Ventas and Welltower:
|SBRASabra Health Care||13.86%||17.50%||3.92%|